REVIUM Rx. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
REVIUM Rx. (RVRC) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $5.52 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5.52M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.16M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.88M.
- 2025-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $18.53M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $5.52M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.16M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $6.88M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $18.53M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $19.41M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $19.71M 10-Q · filed 2026-08-13 |